Archived Investigations
Tempus AI, Inc. (NasdaqGS: TEM)
Tempus and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 28, 2025, Spruce Point Capital Management, LLC reported numerous issues with the Company’s management, operations and financial reporting, including that: (i) Tempus CEO Eric Lefkofsky and his associates have a history cashing out of companies before public shareholders incur losses or lackluster returns; (ii) Tempus’ actual AI capabilities are overstated; (iii) board members and other executives have been associated with troubled companies with restated financial results; (iv) signs of aggressive accounting and financial reporting are present; (v) there are issues with the AstraZeneca and Pathos AI deal that merit scrutiny; and (vi) the Company’s recent financial guidance revision reveals weakness in core operations.
On this news, the price of Tempus’ shares fell $12.67 per share, or 19.23%, from a closing price of $65.87 per share on May 27, 2025, to a closing price of $53.20 per share on May 28, 2025.
The case is Shouse v. Tempus AI. Inc., et al., No. 1:25-cv-06534.